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A Functional Enhancer of Keratin14 Is a Direct
Transcriptional Target of DNp63
Rose-Anne Romano1,2, Barbara Birkaya1,2 and Satrajit Sinha1
Keratin14 (K14) is a prototypic marker of dividing basal keratinocytes where its gene is transcribed at high levels.
Transcriptional regulation of K14 is governed by an evolutionarily conserved functional enhancer marked by
DNase 1 hypersensitive sites present upstream of the gene. This enhancer is sufficient to confer epidermal-
specific gene expression, which is mediated in part by binding of members of activator protein-2 (AP)-2, AP-1,
Ets, and Sp1 families of transcription factors. Here we provide evidence that a keratinocyte-specific nuclear
protein identified as DNp63 binds to a conserved motif within this enhancer. Interestingly, the selective
expression profile of DNp63 in various cell lines correlates with both the nuclear complex and the expression of
K14. Biochemical studies reveal that DNp63 can bind to a specific DNA sequence present in the K14 enhancer
and this binding leads to transactivation. In addition, chromatin immunoprecipitation experiments with DNp63-
specific antibodies demonstrate that the enhancer is occupied by DNp63 in cultured keratinocytes and in
mouse skin epidermal cells in vivo. Finally, we show that ectopic expression of either p63 isoform (DN or TA) can
induce de novo expression of K14. These studies provide a potential mechanism by which DNp63 directly
governs the expression of K14 in a keratinocyte-specific manner.
Journal of Investigative Dermatology (2007) 127, 1175–1186. doi:10.1038/sj.jid.5700652; published online 7 December 2006
INTRODUCTION
Keratins constitute the largest subgroup of the family of
intermediate filaments and represent the most abundant
proteins in epithelial cells (Fuchs and Weber, 1994). These
proteins are divided into type I (acidic) and type II (basic and
neutral) classes based on their sequence. Keratins from these
two classes form obligate heterodimers and are expressed in
tissue- and differentiation-specific manners in epithelial
tissues of various types including simple epithelia, internal
stratified epithelia, outer stratified epithelia, and hair follicles
(Coulombe and Omary, 2002). This distinctive expression of
specific keratin pairs depends largely on the tissue-type,
differentiation status, and the physiological state. For
example, dividing basal keratinocytes of the skin epidermis
express keratin5 (K5) and keratin14 (K14). As these cells exit
the cell cycle and embark on a program of differentiation,
expression of K5 and K14 is downregulated and a new set of
keratins, keratin1 and keratin10 are expressed in the
suprabasal spinous layer (Byrne et al., 1994). The differential
expression of keratins has been useful in marking the
boundaries of the different layers of the skin epidermis and
has often served as surrogate markers to distinguish prolifera-
tion and differentiation states of the skin epidermis. There-
fore, deciphering the molecular mechanisms governing
keratin gene expression is important for better understanding
the regulatory network that underlies epidermal development
and homeostasis.
To characterize transcriptional regulatory mechanisms that
govern the expression of keratin genes, many studies have
focused on the identification of cis and trans regulatory
elements (Byrne, 1997; Eckert et al., 1997). The restricted
expression of K14 in the basal layer of the skin epidermis is
primarily controlled at the level of transcription and regulation
of this process has been extensively studied using various
complementary approaches. DNAse I hypersensitive site (Hs)
mapping of the human K14 gene has identified several Hs in
the 50 region that are present selectively in keratinocytes
(Sinha et al., 2000; Sinha and Fuchs, 2001). Among these Hs
elements are those which correspond to the minimal promoter
(Hs I) and two closely spaced Hs (Hs II and III) at the –1700
and –1400 region. Interestingly, the Hs elements are organized
similarly in the mouse K14 gene, and there is high level of
sequence conservation in the Hs regions, further supporting
the functional relevance and importance of these elements in
controlling K14 expression. This has been experimentally
proven by extensive analysis of these Hs segments by reporter
gene assays in keratinocytes grown in culture as well as in
transgenic mice. Indeed these studies have clearly demon-
strated that the K14 Hs II and III regions act as an enhancer
element that confers high levels of gene expression selectively
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in keratinocytes when assayed by reporter gene assays in
transient transfection experiments. More importantly, this
enhancer can target basal keratinocyte-specific expression of
a reporter gene in transgenic mice. Similar investigative
studies of the K14 partner gene, K5 have also lead to the
identification of several Hs elements that function as critical
regulatory modules, some of which have been characterized
in detail (Kaufman et al., 2002). Collectively these studies
have led to the conclusion that the epidermal and differentia-
tion-specific transcription of these two keratin genes is
governed by complex regulatory elements.
To identify transcription factors that mediate the expres-
sion of the basal keratin genes, these Hs elements have been
subjected to biochemical analysis. These studies show that
basal-specific and differentiation-specific gene expression in
keratinocytes relies on a complex array of regulatory
elements that bind diverse transcription factors belonging to
many families including activator protein-2 (AP)-2, AP-1,
ETS, Sp1/Sp3 and as yet unidentified factors. Many of the
transcriptional activators and repressors that interact with
these Hs sites are quite ubiquitous in their expression pattern
and only a few exhibit some level of keratinocyte-restricted
expression. This has raised an important question, that is,
how is epidermal-specific gene expression achieved? One
hypothesis is that gene expression in basal epidermis is
governed by broadly expressed factors working in a
combinatorial manner. Alternatively, a mechanism may exist
that confers keratinocyte-specific activity on an otherwise
ubiquitously expressed transcription factor by virtue of
specific post-translational modification or interaction with a
co-activator. Finally, it is possible that transcription factors
that are generally restricted to keratinocytes interact directly
with these regulatory elements and mediate cell-type specific
gene expression.
p63 is a p53 homolog that is critical for the development
of the stratified epithelium of the skin as shown by several
recent studies (Mills et al., 1999; Yang et al., 1999, 2002).
Indeed, both loss-of-function and gain-of-function experi-
ments have demonstrated that p63 is important for maintain-
ing epithelial homeostasis (Koster and Roop, 2004b). One
complicating issue in deciphering the biological role of p63 is
the fact that the p63 gene contains two distinct promoters,
resulting in the expression of two major classes of proteins,
one with an amino-terminal trans-activation domain (TAp63)
and one without (DNp63) (Yang et al., 1998). Knockout
studies in mice so far have not examined the relative
contribution of these two major isoforms in orchestrating
the balance between keratinocyte proliferation and differ-
entiation. However, several recent studies utilizing expres-
sion analysis and ectopic overexpression experiments have
led to the postulation of contradictory roles for the TAp63 and
DNp63 isoforms (Koster et al., 2004; Candi et al., 2006;
Laurikkala et al., 2006). What is unequivocally clear
however, is the fact that epidermal cells that lack p63 exhibit
dramatic downregulation in the levels of K14. Although,
there has been a recent report suggesting that loss of
expression of K14 in the absence of p63 is indirectly
mediated by the transcription factor AP-2g, the possibility
that p63 can directly target K14 gene expression has not been
examined thoroughly (Koster et al., 2006).
We describe here a nuclear complex that is restricted to
keratinocytes and binds to a specific conserved sequence
present in the enhancer segment corresponding to Hs II of the
K14 gene. We provide in vitro and in vivo evidence that
DNp63 is a component of this unique complex and that
DNp63 binding is important for the K14 enhancer activity.
Furthermore, our data suggests that contrary to published
data, not only TAp63 but also all isoforms of DNp63 are
capable of inducing K14 gene expression, when ectopically
expressed in cells that normally do not express p63 or K14.
The fact that DNp63 is the predominant isoform expressed
both in cultured keratinocytes and in skin epidermis suggests
it is the critical p63 isoform that governs K14 gene
expression. Our data strongly argues that transcription factors
working in a combinatorial manner govern gene expression
in epidermis and that p63 is a keratinocyte-specific transcrip-
tion factor that potentially serves an important role as a
master regulator in this process.
RESULTS
A novel KSC binds to the K14 enhancer
Previously we characterized an enhancer element located
B1.4 kb upstream of the K14 gene, delineated by a
keratinocyte-specific DNAse I Hs site (Sinha et al., 2000).
We showed that binding of AP-1, AP-2, and the Ets family of
proteins was important for enhancer activity. We identified
an additional nuclear complex binding to an oligonucleotide
containing K14 enhancer sequences from 1433 to 1407
that showed an intriguing behavior in electrophoretic
mobility shift assay (EMSA) (Figure 1a). We named this slow
migrating band keratinocyte-specific complex (KSC), as it was
present only in nuclear extracts from mouse and human
keratinocytes and not from any other cell types including
HepG2 (liver), HeLa (epithelial), NIH3T3 (fibroblast), or B16
(melanoma). The nuclear extracts from the different cell types
were prepared in a similar manner and showed comparable
DNA–protein complexes when tested with other oligonucleo-
tides, suggesting that the extracts were functionally similar
(data not shown). Additional faster moving complexes that
bound to the oligonucleotide containing the KSC-binding
sequence were either also present in other cell types or were
nonspecific as they disappeared in competition experiments
with random oligonucleotides or with high amounts of
competitor DNA. Additionally, KSC binding was stable in
the presence of 0.5 M NaCl suggesting that there is a tight
interaction between KSC and its DNA-binding site (data not
shown).
Binding of KSC is dependent upon specific DNA sequences
To precisely identify the residues that were critical for DNA
binding of KSC, we generated several mutant oligonucleo-
tides (MTs) and performed direct EMSA and competition
assays (see Figure S1 for oligonucleotide sequences). Two of
the single base pair mutations (MT5: GGGCCTG4
GGGACTG) and (MT8: CCTGTCT4CCTATCT) failed to bind
KSC when using either HaCaT or MK nuclear extracts in
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EMSA analysis (Figure 1b). Other mutations either showed
decreased binding to varying degrees (MT1 and MT9) or
showed binding of KSC that was comparable to that of wild-
type oligonucleotides (MT2, MT3, and MT4). These data
suggested that KSC binds to a specific sequence,
GGGCCTGTCTG and that this interaction could be abro-
gated with a single base pair mutation.
To further examine the DNA-binding characteristics of
KSC, we performed competition experiments with MT3 and
MT5 oligonucleotides as well as oligonucleotides containing
consensus DNA-binding sequences for two known transcrip-
tion factors (Figure 1c). In support of the direct EMSA
experiments, MT5 did not compete for KSC binding, whereas
MT3 competed to the same extent as that of the wild-type
oligonucleotides. Surprisingly, KSC was also competed by
oligonucleotides containing a p53-consensus sequence,
whereas similar levels of oligonucleotides containing AP-2-
binding sites had no effect. Upon closer examination, the
KSC site showed considerable sequence similarity with the
p53-consensus sequence RRRCWWGYYY and with the
recently described optimum p63-binding sequence (Ortt
and Sinha, 2006).
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Figure 1. EMSA reveals the presence of specific nuclear complex (KSC) in keratinocytes. (a) EMSA was performed with nuclear extracts from various cell lines
as indicated above each lane. The radiolabeled oligonucleotide probe contained the K14 enhancer sequence (1433 to 1407). Arrow indicates KSC (b)
Mutational analysis of the KSC-binding site identifies critical residues for KSC binding. EMSA was performed with nuclear extracts from HaCaT (lanes1–10) and
MK (lanes 11–20) cells and wild type and various MT containing single base pair substitutions. See Figure S1 for oligonucleotide sequences used in EMSA. (c)
Competition assays show that KSC binds to a p53-like consensus sequence. Wild-type K14 enhancer (lanes 3 and 4), MT3 (lanes 7 and 8), and p53 consensus
(lanes 9 and 10) oligonucleotides abrogated KSC binding (indicated by the arrow). In contrast, oligonucleotides corresponding to MT5 (lanes 5 and 6) and AP2
consensus sequence (lanes 11 and 12) did not affect KSC binding.
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DNp63 protein is present in the KSC
The fact that binding of KSC could be competed by a p53-
binding site prompted us to test if this complex contained any
of the p53 family members. In particular we were interested
in potential binding by p63, as it is highly expressed in
keratinocytes. To test this, we used a panel of commercial
antibodies as well as a polyclonal anti DNp63 antibody (RR-
14) that has been described previously (Romano et al., 2006).
Interestingly, while the corresponding pre-immune serum
had no effect on the KSC complex present in both HaCaT and
MK nuclear extracts, the addition of RR-14 to the DNA-
binding reaction led to the disappearance of the complex and
a clear supershift (Figure 2a). Similar results were also
obtained with the antibody H-129, targeted against the
C-terminus of the p63 protein and antibody Poly6190, which
is a commercial antibody specific for DNp63, similar to RR-
14. On the other hand, antibodies that specifically recognize
the TA isoforms failed to have any effect on the complex, in
agreement with the fact that there is little or no expression of
TAp63 proteins in these cells (data not shown). Taken
together, our data utilizing the various anti-p63 antibodies
clearly demonstrate that the KSC complex contains DNp63.
To further demonstrate binding of DNp63 proteins to K14
enhancer sequences, we ectopically expressed hemaggluti-
nin (HA) epitope-tagged DNp63a, DNp63b, and DNp63g in
HeLa cells, which do not contain KSC. When nuclear extracts
from HeLa cells were tested with KSC oligonucleotides, a
complex appeared specifically in cells transfected with
individual isoforms of DNp63 (Figure 2b). The complex
formed with DNp63a migrated at the same level as the KSC
complex, suggesting that KSC most likely represents the
DNp63a isoform. On the other hand, HeLa cells transfected
with plasmids that expressed DNp63b and DNp63g resulted
in complexes that migrated faster than that present in
DNp63a-transfected cells, presumably, because of the
smaller size of the proteins (compare lanes 2, 5, and 8).
The fact that these complexes were indeed formed by the
ectopically expressed p63 proteins was verified by their
disappearance and supershift with specific antibodies against
both p63 and the HA epitope-tag (lanes 3–4, 6–7, and 9–10).
In summary, these experiments strongly suggest that DNp63,
particularly DNp63a, is responsible for the KSC-binding
activity present in nuclear extracts, although other p63
isoforms can also potentially bind to the K14 enhancer.
It is possible that KSC contains additional proteins present
in the nuclear extract, which help to mediate the binding of
p63 to the K14 enhancer site. To test if recombinant p63 can
directly bind to the KSC site, we expressed and purified
DNp63a from bacteria as a His- or glutathione S-transferase
(GST)-tagged protein. Both of these proteins showed strong
binding to the oligonucleotide containing the KSC site as
shown by EMSA (Figure 2c). Interestingly, the migration of the
His-DNp63a was faster than the native complex present in
keratinocyte extracts. This altered migration pattern could be
a reflection of the fact that over expressed p63 protein may
not be folded properly in bacteria or that in vivo p63 is post-
translationally modified causing it to migrate slowly on a
non-denaturing gel. Alternatively it is possible that the KSC-
binding activity consists of p63 in a complex with another
unknown protein(s).
Co-expression of DNp63 in cell types that co-express K14 and in
vivo occupancy of K14 enhancer by DNp63
Having shown that p63 can bind to the K14 enhancer, our
next objective was to examine if the expression of p63
correlated with that of the expression of K14. For this
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Figure 2. The KSC consists of DNp63. (a) KSC in both HaCaT (lanes 2–6) and MK (lanes 8–12) nuclear extracts is supershifted with antibodies against various
domains of DNp63, whereas corresponding pre-immune serum has no effect (lanes 3 and 9). Lanes 1 and 7 correspond to free probe. (b) HeLa cells (lane 1) were
transfected with HA-tagged DNp63a (lane 2), DNp63b (lane 5), and DNp63g (lane 8). A complex similar to KSC is observed in transfected cells and it is
supershifted with both anti-DNp63 and anti-HA antibodies. (c) Binding of recombinant p63 to the K14 enhancer. Lane 1, free probe; lane 2, HaCaT nuclear
extract; lanes 3 and 4 GST-tagged DNp63a; and His-tagged DNp63a, respectively.
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purpose, we chose two keratinocyte cell lines ME180 and
HaCaT, and three other epithelial cell lines HeLa, MCF-7,
and HEK293 that did not show any detectable KSC binding in
EMSA. Both RT-PCR and Western blot analysis showed that
as expected, both K14 transcripts and protein were expressed
in the keratinocyte cell line HaCaT and ME-180 but not in the
other three cell lines tested (Figure 3a). The expression profile
of DNp63 showed an identical pattern, suggesting that there
is a clear correlation between p63 and K14. Our data confirm
that expression of DNp63 is quite limited and restricted to
epithelial cells derived from stratified epithelia but not in
cells derived from single-layered epithelia.
We further tested the binding of DNp63a to the K14
enhancer in keratinocytes in vivo by performing chromatin
immunoprecipitation (ChIP) experiments. For the ChIP
assays, crosslinked chromatin from HaCaT cells was im-
munoprecipitated with either RR-14 or H-129 anti-p63
antibodies and the co-precipitation of the K14 enhancer
region was ascertained by PCR. We utilized a set of primers
(P1 and P2) that amplify the enhancer region of K14 and as a
control we used a set of primers (P3 and P4) that amplify a
segment of K14 that corresponds to no known Hs and has no
reported regulatory role. As an additional negative control we
used primers that amplify a genomic segment corresponding
to glyceraldehyde-3-phosphate dehydrogenase. As shown in
Figure 3b, after immunoprecipitation of cross-linked chro-
matin we found that there was specific enrichment of DNp63
to a DNA segment that corresponds to the Hs II with both
antibodies against p63 compared to IgG control. In contrast,
we did not observe any localization of DNp63 to the control
K14 segment or glyceraldehyde-3-phosphate dehydrogenase
as demonstrated by the negative PCR results. Similar results
were obtained from three independent ChIP experiments. As
our experiments thus far were performed with keratinocytes
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Figure 3. Expression of DNp63 correlates with the expression profile of K14 and DNp63 occupies the K14 Hs II region. (a) In the upper panel, total RNA
was isolated from various epithelial cell lines and RT-PCR was performed using primers, which specifically amplify DNp63 and K14. b-Actin serves as a control.
In lower panel total protein was isolated and protein levels of DNp63 and K14 were examined by Western Blot. Histone H1 serves as a loading control.
(b) ChIP was performed on HaCaT cells using two separate antibodies recognizing DNp63a as well as a nonspecific IgG, as indicated. Primer set 1 (P1–P2)
amplifies the K14 enhancer. Primer set 2 (P3–P4), amplifies a region that is not conserved and serves as a negative control. Input represents PCR amplification of
1% of the genomic DNA. Ab, antibody. On left is shown a representative result of PCR products from ChIPed samples run on an agarose gel, on right are
results obtained from real-time PCR experiments. (c) ChIP was performed on mouse skin similar to that described in (b). Primer set P5–P6 amplifies the mouse
K14 enhancer whereas primer set P7–P8, amplifies a region further upstream that is not conserved. Input represents PCR amplification of 1% of the
genomic DNA. Ab, antibody. On left is shown a representative result of PCR products from ChIPed samples run on an agarose gel, on right are results obtained
from real-time PCR experiments. (d) The sequence of the K14 enhancer from various species was obtained from the respective genome database and
aligned using the ClustalW program. The K14 enhancer shows remarkable sequence conservation among the four species examined as indicated by *.
The putative binding sites for various transcription factors are denoted by a horizontal bar.
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grown in culture, we asked if DNp63a is also present at the
K14 enhancer in mouse skin epidermal cells. For this
purpose, we repeated ChIP experiments with several in-
dependently isolated newborn mouse skin samples. Similar to
data obtained from HaCaT cells, PCR with primers P5 and P6
corresponding to the mouse K14 enhancer region, showed
specific enrichment with immunoprecipitated DNA from two
anti-p63 antibodies and not with control IgG (Figure 3c).
These PCR products were significantly stronger than those
obtained under similar conditions with control primers P7
and P8 that amplified a segment further upstream of the
mouse K14 gene or with primers that amplified a genomic
segment of mouse glyceraldehyde-3-phosphate dehydrogen-
ase. Taken together these experiments strongly support the
notion that both in human keratinocytes in culture and in
mouse skin in vivo, DNp63a is present at the K14 enhancer
segment.
Interestingly, the p63-binding site in the K14 enhancer
sequence shows a high degree of sequence conservation
between human, cow, mouse, and rat sequences; 24 out of the
27 nucleotides are identical in this stretch, further validating
the functional significance of this element (Figure 3d).
p63 can activate the K14 enhancer in keratinocytes
Our previous studies with the K14 enhancer segment have
shown that individual transcription factor binding motifs such
as AP-1, AP-2, and Ets exhibited activity in reporter gene
assays in transient transfection experiments. To test the
potential activation properties of p63-binding sites, we
generated two constructs, (p63)2K14Luc and (p63)3K14Luc
containing two and three copies, respectively, of the p63-
binding site (1433 to 1407 of the human K14 gene)
upstream of the K14 minimal promoter and luciferase
reporter gene. In transient transfection experiments in
keratinocytes, (p63)2K14Luc and (p63)3K14Luc showed 3–7-
fold more activity of luciferase as compared to the construct
K14Luc, containing just the minimal K14 promoter (Figure
4a). To test if the transcriptional activation by the p63-binding
site was also observed with a heterologous promoter, we
generated an additional construct (p63)3TKLuc, containing
three copies of the 1433 to –1407 segment of the human
K14 gene upstream of the minimal promoter of thymidine
kinase (TK). To address specificity, we also generated a
similar construct, (p63MT)3TKLuc containing three copies of
a mutated p63-binding site (MT5 as described previously). As
shown in Figure 4a, the (p63)3TKLuc construct showed strong
activation in keratinocytes (12-fold) compared to the TK
promoter. This activation was significantly reduced with the
mutant construct.
Finally, to examine the activation properties of p63, we
performed transient transfection experiments in Ptk2 cells to
test if p63 activates the K14 enhancer. Ptk2 cells have no
detectable p63 or K14 expression as described previously and
supported by the lack of p63 DNA-binding activity in EMSA
as shown in Figure 1. Our prior data showed that a 700 bp
K14 enhancer segment is highly active in keratinocytes and
not in many other cell types (Sinha et al., 2000). The K14
enhancer construct 700TK was transfected into Ptk2 cells
along with either control expression plasmid pCMVHA or
plasmids that expressed various isoforms of p63. A CMVLacZ
plasmid was co-transfected to serve as an internal control for
transfection efficiency. As data presented in Figure 4b
indicate, expression of both DNp63a and DNp63g isoforms
led to higher transcriptional activity of the K14 enhancer
element (B6-fold compared to the empty vector). Similarly,
the TA isoform also activated 700TK construct and the
induction was similar to that of the DN isoforms. This effect
was specific because the p63 proteins failed to activate the
700TKMT reporter plasmid, which contained a mutation in
the p63-binding site (MT5). These data suggest that DNp63
regulates the expression of the K14 enhancer at the
transcriptional level.
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Figure 4. Various p63 isoforms can activate the K14 enhancer in reporter gene assays. (a) In the upper panel, a luciferase construct containing two and
three copies of the p63-binding site upstream of the K14 minimal promoter is highly active in keratinocytes. In the lower panel, constructs containing three
copies of the p63-binding site upstream of a heterologous TK promoter show high levels of activity. In contrast, (p63MT)3TKLuc containing three copies
of a mutated p63-binding site is weakly active. (b) Various isoforms of p63 can activate the K14 enhancer. 700TK and 700TKMT were co-transfected with
expression plasmids encoding various isoforms of p63 into Ptk2 cells. Luciferase values were determined and normalized against b-galactosidase values.
The corrected luciferase values for cells transfected with empty vector pCMV-HA were set at 1.
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Ectopic expression of multiple isoforms of p63 can induce
de novo expression of K14
Prior studies have shown that only the TA isoform of p63 can
induce K14 expression when ectopically expressed in
epithelial cells (Koster et al., 2004). Based on our EMSA,
ChIP, and transfection data we postulated that DNp63 is also
capable of acting as a transactivator of K14 gene expression.
To test this experimentally, we transfected Ptk2 cells with
various expression plasmids encoding DNp63 and TAp63.
Initially we examined whether K14 messenger RNA is
induced by DNp63a and DNp63g by performing RT-PCR
(Figure 5a). Unlike control cells transfected with an empty
vector, cells that expressed either of these isoforms or TAp63a
gave rise to the expected PCR product. Sequencing the PCR
product confirmed that indeed it was the rat kangaroo isoform
of K14 (data not shown). Western blot analysis on the
transfected cells with antibodies against K14 and the epitope-
tag present on p63 corroborated that the various isoforms of
p63 are capable of inducing K14 (Figure 5b). We further
verified our observation of K14 induction by performing
immunofluorescence studies with the three major isoforms of
DNp63 (DNp63a, DNp63b, and DNp63g) and TAp63a. As
illustrated in Figure 5c, in cells that express p63, as shown by
anti-HA nuclear staining, a cytoplasmic K14 network was also
observed. Although we believe that the induction of K14 is
mediated by direct DNA-binding activity of p63, it is also
possible that it could be caused by an indirect effect. To test
this we generated an expression construct, DNp63aMT that
contained a mutation in the conserved DNA-binding region
(R304W). This p63 mutation is found in a subset of human
patients with the ectrodactyly-ectodermal dysplasia-clefting
syndrome (van Bokhoven and McKeon, 2002). As expected,
recombinant p63 protein containing this mutation failed to
bind to DNA when tested by EMSA (data not shown). As our
immunofluorescence studies clearly indicate, although
DNp63aMT protein was expressed and localized to the
nuclei, K14 induction was not observed (Figure 5c). Taken
together, our studies demonstrate that ectopic expression of
all major isoforms of p63 induces K14 expression and that this
induction is dependent upon the DNA-binding activity of p63.
DISCUSSION
K14 is a predominant cytoplasmic intermediate filament
protein that is expressed at high levels in the proliferating
basal cells of the mature adult epidermis. In addition, it is
among the earliest epidermal markers, whose expression
coincides with commitment of the single-layered surface
ectoderm to an epidermal cell fate and stratification
during mouse embryonic skin development (Byrne et al.,
1994). Multiple signaling pathways and transcription factors
ensure the proper spatial-temporal expression of specific
markers such as K14, during the carefully orchestrated
epidermal morphogenesis program. Transgenic and knockout
mice studies have clearly demonstrated that p63, a member
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Figure 5. Expression of K14 can be induced by both TAp63 and DNp63. (a) Ptk2 cells were transfected with HA-epitope tagged plasmids encoding
various isoforms of p63. Total RNA was isolated and RT-PCR was performed using primers, which specifically amplify K14. b-Actin serves as a control. (b) Ptk2
cells were transfected as described above. Total protein was extracted and Western blot was performed. Top panel demonstrates protein expression levels
of various HA-tagged p63 isoforms and middle panel shows expression of K14. Tubulin in the lower panel serves as a loading control. (c) Ptk2 cells were
transfected with plasmids encoding various isoforms of p63 as depicted on left. Cells were stained with antibodies detecting HA (red), and K14 (green).
Nuclei are stained with 40,6-diamidino-2-phenylindole (blue). A merge is shown on right.
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of the p53 family of proteins, is one such factor that plays
an important role during this process (Koster and Roop,
2004a).
During the course of our investigation of a functional
enhancer that is important for the transcriptional regulation of
the K14 gene, we identified a DNA-binding complex that
binds to a conserved sequence and is highly restricted to
keratinocytes. Here we provide evidence that this complex is
p63, specifically the DNp63a isoform. As supported by our
EMSA, keratinocytes express robust amounts of DNp63 and in
nuclear extracts, DNp63a accounts for the majority of the
DNA-binding activity. In view of the ambiguity regarding the
expression levels of the various p63 isoforms in vivo, our data
provides valuable information regarding the relative func-
tional status of these proteins as judged by DNA-binding
activity to a specific sequence. Furthermore, as evident by
our data presented here and published studies on several p63
target genes, it is becoming increasingly clear that DNp63
isoforms do not function merely as dominant negatives, but
that similar to their TA counterparts, given the right cellular
and target context these isoforms can also activate transcrip-
tion (Barbieri and Pietenpol, 2006).
The fact that DNp63 and K14 are co-expressed in
keratinocyte cell lines and that DNp63 activates the K14
enhancer suggests that DNp63 is an important transcriptional
regulator of K14. This is further supported by the complete
absence of K14 in p63 null keratinocytes and the fact that
knockdown of p63 in keratinocytes leads to downregulation
of K14 expression (Figure S2) (Koster et al., 2004). However,
the regulatory mechanisms that govern K14 gene expression
may be more complex in skin epidermis in vivo as compared
to cells grown in culture. For example, although there is clear
and dramatic downregulation of K14 messenger RNA and
protein levels in p63 null embryonic and new born skin, in
adult animals the situation appears to be different. In a tissue-
specific knockout mouse model, there is persistent K14
expression in the basal cells of the epidermis despite the
ablation of p63 in adult skin (Keyes et al., 2005). One
explanation for this phenomenon is that in this case, Cre-
mediated p63 knockout in adult skin might not be complete
as evident by the presence of persistent cells that express
detectable levels of p63. These low levels of p63 may be
sufficient to sustain some level of K14 expression. Alterna-
tively in the absence of p63, it is probable that other
transcription factors may function in a compensatory manner
allowing at least partial but detectable K14 expression.
Finally it is also possible that K14 gene expression during
early embryonic skin development, a period of dramatic
proliferative activity and commitment to the epidermal
lineage, may be more dependent upon the levels of p63
and that these requirements are relaxed in adult skin
epidermis.
It is interesting to note that in the skin-specific p63
knockout animals, the expression of K14 in skin epidermis
was examined only by immunofluorescence studies. It is
likely even major changes in the transcript levels may not
always lead to dramatic difference in protein levels that are
easily detectable. Indeed, our knockdown experiments in cell
culture seem to point in that direction. Interestingly, whereas
we detect a significant loss of K14 messenger RNA levels
upon p63 knockdown by small interfering RNA (90%),
protein levels are down only 30% (Figure S2). Taken together,
these studies suggest that the regulation of K14 gene
expression by p63 is a complex process that should be
examined in a context-dependent manner.
What is clear however is that the expression of K14 is
governed by a network of transcription factors that bind to
conserved regions including p63-responsive elements that
are located in the keratinocyte-specific Hs II region. It is likely
that Hs regions other than the one described in this study may
also harbor functional p63-binding sites. Indeed, our
preliminary in silico sequence examination and biochemical
studies have shown that that the proximal promoter of K14
(corresponding to Hs I) contains at least two p63-binding sites
(data not shown). This is in agreement with a recent report
that shows DNp63 is recruited to the K14 promoter by ChIP
experiments (Candi et al., 2006). On the other hand, unlike
the observations of Candi et al. (2006) who do not detect p63
localization to the K14 enhancer element, our ChIP experi-
ments clearly demonstrate the interaction of p63 with K14
enhancer element. This disparity is likely due to variations in
experimental conditions such as choice of antibodies
utilized; we used two different antibodies (RR-14 and H-
129) proven to be very effective in ChIP experiments,
whereas experiments by Candi et al. (2006) were performed
with a different commercial antibody. The fact that we have
obtained similar ChIP results for both the mouse and human
K14 enhancer and the additional biochemical evidence
presented in this paper strongly supports the idea that
DNp63 plays an important role in regulating the expression
of K14 through binding to both the enhancer and promoter
elements.
It will be interesting to examine if DNp63 can also regulate
the expression of K5, the K14 partner gene that is highly
expressed in basal keratinocytes. Underscoring this prospect
is the fact that p63 null keratinocytes also demonstrate loss of
K5 expression. However, while transient transfection studies
have clearly shown that K14 gene expression can be strongly
induced by p63, under similar conditions K5 induction is
weak. One explanation could be that the induction of K5 may
require additional cofactors, possibly in conjunction with
p63, which are limiting in the cell lines that were utilized for
these experiments. On the other hand, it is possible that the
transcriptional regulatory mechanisms are different for K5, as
supported by the fact that the appearance of K5 precedes that
of K14 during mouse skin development (Lu et al., 2005). The
hypothesis currently under investigation in our laboratory is
that the regulation of K5 is also directly governed by DNp63
through potential p63-responsive elements in the previously
described Hs elements of the K5 gene.
The data presented in this paper complements and
augments recent studies by the Roop laboratory, which
suggests that induction of K14 expression during epidermal
morphogenesis requires an additional transcription factor,
AP-2g. According to their model, TAp63 specifically associ-
ates with the AP-2g promoter at E8.5 day as demonstrated by
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ChIP experiments (Koster et al., 2006). Moreover, when over
expressed, TAp63 induces the expression of AP-2g and the
resulting induction of AP-2g by TAp63 is required for
expression of K14 during embryonic skin formation. Our
studies using the K14 enhancer reaffirm the idea that p63 and
AP-2 proteins both directly or indirectly play a critical role in
governing K14 expression as illustrated in our model
(Figure 6). Interestingly, the interplay between these two
proteins is also evident in the study of a functional enhancer
for the p63 gene, where AP-2 binds to this conserved element
and cooperates with p63 to induce its activity (Antonini et al.,
2006). In view of the recent data demonstrating direct
functional interaction between p53 and AP-2, it is tempting
to speculate that a complex and interactive network between
these two families of proteins may play an important role in
integrating developmental cues (Li et al., 2006; Stabach et al.,
2006).
One aspect of p63 biology that remains unsettled is the
conflicting data from different laboratories regarding the
expression profile of TA and DNp63 isoforms, particularly
during embryonic development (Koster et al., 2004; Laur-
ikkala et al., 2006). It is possible that the variable results
reflect the complex expression pattern of these proteins, lack
of reagents such as isoform-specific antibodies and the
difficulties associated with manipulation of mouse embryos
at early stages of development. What is clear however, from
data obtained by many laboratories, is that the TA and
DNp63 proteins may have overlapping as well as unique
functions in keratinocyte development and differentiation.
Teasing out the relative contribution of each of these isoforms
is an interesting challenge for the future and awaits the
development of new tools and strategies.
MATERIALS AND METHODS
Plasmids
Recombinant plasmids were constructed using standard molecular
biology protocols. To generate expression plasmids for the various
p63 isoforms, the complementary DNAs were cloned into the BglII
and XhoI sites of the pCMV-HA vector (Clontech-BD Biosciences,
Palo Alto, CA). To facilitate expression in bacteria, mouse DNp63a
was subcloned into BamHI and XhoI restriction enzyme sites of the
pGEX-5X-1 (Amersham, Pistcataway, NJ) vector, and BamHI and
HindIII restriction enzyme sites of the pCOLD vector (Takara Mirius
Bio, Madison, WI). Each construct was sequence verified to ensure
that the construct expressed p63 as an in-frame fusion protein with
GST and His tags. The LTK and LK14 constructs containing the TK
and the K14 minimal promoters in the luciferase reporter pGL3-basic
vector (Promega, Madison, WI) have been described before. A K14
enhancer construct, 700TK, which contains a –2000 to –1300
segment of the K14 50 region was used as a template to generate
700TKMT by using a two-step PCR approach. Multimerized
constructs (p63)2K14Luc, (p63)3K14Luc, (p63)3TKLuc, and
(p63MT)3TKLuc were generated by cloning oligonucleotides con-
taining two or three copies of the wild type or the mutant p63-
binding sequences in the LTK or the LK14 plasmids.
Expression of GST and His-p63 fusion proteins in bacteria
GST-DNp63a and His-DNp63a expression plasmids were trans-
formed into Escherichia coli (strain BL21 DE3). Bacteria were
cultured in Luria–Bertani media in the presence of 50mg/ml
carbenicillin to midlog phase at 371C and GST fusion protein
purification was performed as described previously (Romano et al.,
2006). The production and purification of the His-tagged p63 proteins
from bacteria were performed according to the standard protocols.
Briefly, bacteria were induced at 151C by addition of IPTG (isopropyl-
beta-D-thiogalactopyranoside). Cells were centrifuged and lysed by
sonication following which the lysed extracts were centrifuged at
8,500 g for 30 minutes. The supernatant was mixed with Ni-
charged His-Bind resin (Novagen, Madison, WI) and the mixture
agitated for 30 minutes at room temperature. The His-bind resin was
washed thoroughly first with binding buffer (0.5 M NaCl, 20 mM Tris-
HCl, 5 mM imidizole, pH 7.9) followed by wash buffer (0.5 M NaCl,
60 mM imidizole, and 20 mM Tris-HCl, pH 7.9). The recombinant
proteins were eluted in buffer containing 1 M imidazole, 0.5 M NaCl,
K14 enhancer K14 minimal promoter
K14
Figure 6. Model depicting the roles various p63 isoforms play in regulating K14 gene expression. Recently, Koster et al. (2004, 2006) have demonstrated
that TAp63 can indirectly regulate K14 gene expression by upregulating AP-2g. In addition, Candi et al. (2006) have determined that DNp63 is recruited
to the minimal promoter region of K14. We propose that DNp63a binds directly to the K14 enhancer inducing de novo expression of K14 in partnership
with other transcription factors as described previously (Sinha et al., 2000).
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and 20 mM Tris-HCl, pH 7.9. Purified His-DNp63a and GST-DNp63a
proteins were run on a 12% SDS-PAGE gel, which was then stained
with Coomassie Brilliant Blue to ascertain protein purity and quantity.
Cell culture
HeLa (human cervical adenocarcinoma), ME-180 (human cervical
squamous cell carcinoma), NIH3T3 (mouse fibroblasts), HEK293
(human embryonic kidney epithelial), and HaCaT (human epidermal
keratinocytes) cells were grown in DMEM supplemented with 10%
fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomy-
cin. A spontaneously immortalized MK cell line, was grown as
described before (Romano et al., 2006). Ptk2 (rat kangaroo kidney
epithelial) cells were grown in Modified Eagle’s Medium with 10%
fetal bovine serum, 1% Modified Eagle’s Medium non-essential
amino acid solution, 100 U/ml penicillin, and 100 mg/ml streptomy-
cin. MCF-7 (human breast adenocarcinoma) cells were grown in
RPMI (Rosewell Park Memorial Institute) media supplemented with
10% fetal bovine serum and antibiotics.
RT-PCR
Total RNA from HeLa, HEK293, MCF-7, ME-180, HaCaT, and
transfected Ptk2 cells was isolated and purified by TRIzol (Invitrogen,
Carlsbad, CA) according to established protocols. Two mg of total
RNA was reverse transcribed with the iScript complementary DNA
synthesis kit (Bio-Rad, Hercules, CA). All primers were designed to
span at least one intron. Primers specific for DNp63a consist of a
forward primer 50-GTACCTGGAAAACAATGCCCAG-30 and a re-
verse primer 50-GAGGAATGTGATCGTGTCTGG-30. A fragment of
human K14 was PCR amplified from the first strand complementary
DNA using the forward primer 50-CCAGTTCTCCTCTGGATCGCAG-
30 and the reverse primer 50-GGATCTTCCAGTGGGATCTGTGTC
CA-30. b-Actin was used as a control and a 425 bp fragment was
amplified with specific primers 50-GCTCACCATGGATGATGA
TATCGC-30 and 50-GATAGCATAGCCTGGATAGCAACG-30. PCR
amplifications were carried out using Hot Start Taq Polymerase
(Sigma-Aldrich, St Louis, MO). Reactions were performed for 35
cycles of denaturation at 941C for 20 seconds, annealing at 56–621C
for 20 seconds, and extension at 721C for 60 seconds.
Preparation of nuclear extracts and EMSAs
Nuclear extracts from most cell types were prepared, and EMSAs
were performed as described (Romano et al., 2006). Nuclear extracts
from B16 (mouse melanoma), PC12 (rat pheochromocytoma), and K-
562 (human chronic myeloid) cells were obtained from commercial
source (Active Motif, Carlsbad, CA). Competition assays were
performed by incubating the nuclear extracts with 20- or 100-fold
excess cold oligonucleotides before addition of radiolabeled probe;
1mg of poly(dA-dT)  poly(dA-dT) was added to each reaction as
nonspecific DNA. For supershift assays, nuclear extracts were
incubated with 1 ml of relevant antibodies for 15 minutes before
radiolabeled oligonucleotides were added to the reaction. Anti-
bodies used in EMSAs were anti-HA antibody (3F10) (Roche,
Indianapolis, IN), anti-p63 (RR-14), Poly6190 (Biolegend, San
Diego, CA) and H-129 (Santa Cruz Biotechnology, Santa Cruz, CA)
Western blot
Ptk2 cells were plated at 125,000 cells/well in a six-well culture
plate 1 day before transfection. Cells were transfected using
FUGENE 6 transfection reagent (Roche) with 1mg each of expression
plasmid constructs encoding the various HA-tagged p63 isoforms.
Cells were harvested 48 hours post-transfection, washed in phos-
phate-buffered saline (PBS), and centrifuged at 2,000 r.p.m. for
5 minutes. Cell extracts were prepared by resuspending the pellets in
Laemmli Sample Buffer (Bio-Rad). Approximately equivalent
amounts of each sample was denatured at 961C for 10 minutes,
separated by SDS-PAGE, and transferred to a polyvinylidene fluoride
membrane. The membrane was blocked with 5% non-fat dry milk
diluted in 150 mM NaCl, 10 mM Tris pH 7.5, and 0.1% Tween 20.
Primary antibodies used (1:2,000 dil) include rat anti-HA, rabbit
anti-K14 (AF64) (Covance, Berkeley, CA), mouse anti-Histone H1
AE4 (Santa-Cruz), mouse anti-tubulin (Chemicon, Germany), and
rabbit anti-p63 (RR-14). Secondary antibodies (1:5,000 dil) used
were ImmunoPure goat anti-rat, goat anti-rabbit, and goat anti-
mouse, horseradish peroxidase-conjugated IgG (Pierce, Rockford,
IL). Chemiluminescence detection of horseradish peroxidase-con-
jugated secondary antibodies was performed using the horseradish
peroxidase stabilizer kit from KPL (Gaithesburg, MD).
Immunofluorescence
Ptk2 cells were plated at 75,000 cells/well in 12-well cell culture
plates lined with micro-cover glasses. Cells were transfected at 30%
confluency with 1mg of expression plasmid containing HA-tagged
mouse TAp63a, DNp63a, DNp63b, DNp63g, and DNp63aMT. Forty-
eight hour post-transfection, cells were fixed on cover glasses with
4% paraformaldehyde for 10 minutes and washed in PBS for
30 minutes. Cells were then permeabilized with 0.1% Triton X-100
(diluted in PBS) for 3 minutes, rinsed briefly in PBS, and blocked with
5% BSA for 2 hours. Samples were then incubated for 1 hour at room
temperature with rat anti-HA (Roche) and rabbit anti-Keratin 14
(Covance) at (1:500 dil) in 5% BSA. Primary incubations were
followed by several washes in PBS for 30 minutes. Samples were
further incubated at room temperature for 45 minutes with 40,6-
diamidino-2-phenylindole (Molecular Probes Inc. Eugene, OR)
along with secondary antibodies, anti-rat IgG Alexa 568 (Molecular
Probes), and anti-rabbit IgG FITC (BD Biosciences) (1:500 dil). Cover
glasses were then mounted on microscope slides and viewed with a
Nikon FXA fluorescence microscope. Images were captured using a
Nikon digital camera and analyzed using ImageJ, Adobe Photoshop,
and Adobe Illustrator software.
Transient transfections and reporter assays
MK cells were plated in six-well plates the day before transfection.
Transfections were performed using Fugene 6 reagent (Roche)
according to the manufacturer’s instructions. One microgram of
each luciferase reporter construct was transfected per well along
with 0.25 mg of CMVLacZ plasmid DNA to serve as an internal
control for transfection efficiency. Reporter assays were performed
as described previously (Romano et al., 2006). Means and SD were
calculated based on data from three independent transfection
experiments.
ChIP assays
ChIP experiments with anti-p63 antibodies from cells in culture have
been described previously (Romano et al., 2006). For in vivo ChIP,
newborn mouse skin samples were isolated and treated with Dispase
II (Roche) overnight at 41C. The epidermis was separated, washed
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five times with PBS and crosslinked with 1% formaldehyde in PBS at
room temperature for 15 minutes. The crosslinking process was
stopped by adding 0.125 M glycine for 3–5 minutes followed by five
washes with PBS. The epidermis was finely chopped and standard
ChIP procedures were followed. ChIPed DNA was subjected
to routine PCR as well as real-time PCR. Real-time PCR was
performed using an icycler IQ real-time detection System (Bio-Rad)
according to manufacturers recommendation with SYBR green
for detection. Cycling parameters were: 951C for 8 minutes, followed
by 35 cycles of 951C for 15 seconds, and 601 C for 1 minute.
Primers used to amplify the 50 region of the human K14 gene were
P1 (50-GCTCCTAGGCCACAGTAGTGG-30), P2 (50-GAGGAATGT
GATCGTGTCTGG-30), P3 (50-GATGTGAGATCCTCACCATAGG-30)
and P4 (50-CTGTGCTGAGAAGTCTGTCC-30). Human glyceralde-
hyde-3-phosphate dehydrogenase control primers were forward
50-GAGTACGCTGCAGGGCCTCACTCCTTTTGC-30 and reverse
50-CATGCCAGTGAGCTTCCCGTTCAGCTCAG-30. The following
primers were used to amplify the 50 region of the mouse K14 gene:
P5 (50-TCAGCCTCAAGAGTACATCTTAGC-30), P6 (50-AACCCA
GCTAATTCTGGTTCAGAG-30), P7 (50-TGTGGGCTTCTACACCAA
GGC-30), P8 (50-TGTGGTTAGTGAGTCTCCTAC-30). Mouse glycer-
aldehyde-3-phosphate dehydrogenase control primers were
forward 50-GCTAGGACTGGATAAGCAGG-30 and reverse 50-GG
TCCGGCTTGCACACTTC-30. All experiments involving ani-
mals were performed according to SUNY at Buffalo IACUC
protocols.
Knockdown of p63 by small interfering RNA
HaCaT cells were seeded in 100-mm dishes. Transfections were
performed when cells were 30–40% confluent with SiGenome
SMART pool Human TP73L NM-003722 (Dharmacon, Lafayette,
CO) using Lipofectamine 2000 (Invitrogen, San Diego, CA). Cells
were collected B60 hours after transfection and analyzed for
knockdown of p63 by real-time PCR and Western blot analysis.
RNA was extracted from small interfering RNA-transfected and
control HaCaT cells by using TRIzol (Invitrogen, San Diego, CA).
Total RNA (2 mg) was reverse transcribed with the iScript comple-
mentary DNA synthesis kit (Bio-Rad). Real-time PCR was performed
as described above. Two separate RNA preparations from transfected
cells were evaluated and PCR reactions were performed at least
twice in triplicates. The relative transcript level of p63 and K14 in
comparison with the reference house keeping gene b2-microglobulin
was determined by using Pfaffl method. b2-Microglobulin was
amplified with forward primer 50-CTTGTCTTTCAGCAAGGACTG
G-30 and reverse primer 50-CATGATGCTGCTTACATGTCTC-30.
Primers for p63 and K14 were the same as described for RT-PCR.
Western blot analysis was performed with rabbit anti-K14 (AF64)
(Covance), mouse anti-tubulin (Chemicon), and rabbit anti-p63
(RR-14).
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